The condition of former President Nelson Mandela is critical, the South African presidency has said, two weeks after the 94-year-old anti-apartheid icon was admitted to a hospital with a recurrent lung infection. President Jacob Zuma and African National Congress deputy president Cyril Ramaphosa visited Mandela on Sunday evening, Mac Maharaj, presidential spokesman, said in a statement.
Former South African president and anti-apartheid icon Nelson Mandela was discharged from hospital on Saturday where he spent 10 days for pneumonia treatment.
Revered anti-apartheid icon and former South African president Nelson Mandela was "breathing without difficulty" after being treated for pneumonia, the presidency said on Saturday as the 94-year-old leader spent a third day at an undisclosed hospital. "Doctors advise that due to the lung infectio
South Africa's anti-apartheid icon Nelson Mandela is suffering from recurring lung infection, but is responding to treatment, the presidential office announced on Tuesday, as his wife Graca Machel said "it's heartsore seeing the sparkle dimming".
I can actually say I know what it's like to be around someone who was literally a living legend, says film director Kabir Khan.
Former South African President Nelson Mandela has spent a second day in hospital in a "serious but stable" condition with a renewed lung infection that has triggered worldwide concern for the anti-apartheid icon.
The presidency of South Africa has denied reports about former president Nelson Mandela being in a permanent vegetative state.
Former South African President Nelson Mandela has spent his 50th day in hospital with his condition still critical battling a recurrent lung infection, even as a media report said that he has undergone a "minor" medical procedure and survived two "scares" in the past week.
An ambitious exhibition tells the story of India as also the history of the world.
Princess Shivranjani of Jodhpur is breathing new life into dead forts and quietly changing the house of Marwar.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances